Top Markets
Coin of the day
EGF Theramed Health Corp. EGF Theramed Health Corp.

EGF Theramed Health Corp.

TMED
Rank in Stocks #39223
EGF Theramed Health Corp. focuses on providing psychedelic-based therapies to... EGF Theramed Health Corp. focuses on providing psychedelic-based therapies to address various mental health challenges. The company's products are specifically utilized in the treatment of conditions such as intractable depression, anxiety disorders, post-traumatic stress disorder (PTSD), and general depression. Established in 2011, this firm operates from its main headquarters in Vancouver, Canada.
Share Price
$0.05137558
Last synced: 2026-06-26
Market Cap
$596.81K
Change (1 day)
0.00%
Change (1 year)
-11.29%
Country
CA
Trade EGF Theramed Health Corp. (TMED)

Category

P/E ratio for EGF Theramed Health Corp. (TMED)
P/E ratio as of 2026 TTM: 0
According to EGF Theramed Health Corp. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for EGF Theramed Health Corp. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.